menu
    • menu

    Company profile for Nova

    NEW Drugs in Dev: 7
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    EXCIPIENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    nova experts come from a wide range of backgrounds, including material sciences, economics, chemistry, biology, environmental sciences, biotechnology and physics. Our departments (Sustainability, Economy & Policy, Technology & Markets, Communication) work closely together. This gives nova a unique understanding of the bio-based economy, markets and trends and enables us to support your business.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NovaGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Chemiepark Knapsack Industriestraße 300 50354 Hürth
    Telephone
    Telephone
    +49 (0)2233 4814 40
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://nova-institute.eu/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nova Research Laboratories, LLC announces acquisition of CiPA Lab
    Nova Research Laboratories, LLC announces acquisition of CiPA Lab

    03 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nova-research-laboratories-llc-announces-acquisition-of-cipa-lab-301787644.html

    PR NEWSWIRE
    03 Apr 2023
    Share Share
    Nova Leap Health Corp. Posts Record Revenues for 5th Consecutive Quarter
    Nova Leap Health Corp. Posts Record Revenues for 5th Consecutive Quarter

    12 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/12/2442599/0/en/Nova-Leap-Health-Corp-Posts-Record-Revenues-for-5th-Consecutive-Quarter.html

    GLOBENEWSWIRE
    12 May 2022
    Share Share
    Nova Leap Health Corp. Grants Deferred Share Units
    Nova Leap Health Corp. Grants Deferred Share Units

    01 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/01/2415089/0/en/Nova-Leap-Health-Corp-Grants-Deferred-Share-Units.html

    GLOBENEWSWIRE
    01 Apr 2022
    Share Share
    Nova Leap Posts Record Revenues for Q4 and 2021 Annual Financial Results
    Nova Leap Posts Record Revenues for Q4 and 2021 Annual Financial Results

    10 Mar 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/03/10/2401469/0/en/Nova-Leap-Health-Corp-Posts-Record-Revenues-for-Fourth-Quarter-and-2021-Annual-Financial-Results.html

    GLOBENEWSWIRE
    10 Mar 2022
    Share Share
    Gennova's mRNA-based Covid vaccine gets nod for Phase 2/3 clinical trials
    Gennova's mRNA-based Covid vaccine gets nod for Phase 2/3 clinical trials

    24 Aug 2021

    // BUSINESS-STANDARD

    https://www.business-standard.com/article/current-affairs/india-says-homegrown-mrna-covid-shot-safe-in-early-trial-121082400910_1.html

    BUSINESS-STANDARD
    24 Aug 2021
    Share Share
    Substitution instrument to address shortage of PROGYNOVA
    Substitution instrument to address shortage of PROGYNOVA

    12 Aug 2021

    // TGA

    https://www.tga.gov.au/alert/substitution-instrument-address-shortage-progynova-estradiol-valerate-tablets-multiple-strengths

    TGA
    12 Aug 2021
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search